(Q44915586)
Statements
1 reference
Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer (English)
1 reference
Jean-Yves Douillard
1 reference
György Losonczy
1 reference
Primo N Lara
1 reference
Kazuhiko Nakagawa
1 reference
Joachim von Pawel
1 reference
Mark J McKeage
1 reference
Istvan Albert
1 reference
Martin Reck
1 reference
Dae-Seog Heo
1 reference
Xiaolin Fan
1 reference
Abderrahim Fandi
1 reference
Giorgio Scagliotti
1 reference
27 June 2011
1 reference
1 reference
29
1 reference
22
1 reference
2965-2971
1 reference
Identifiers
1 reference
1 reference